Venlafaxine Hydrochloride
Product Images NDC 68071-1728

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68071-1728). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 1728 9)

This is a description of a medication called Venlafaxine Hydrochloride 75mg. It comes in two forms, E-R Capsules and a tablet. The lot number for both is 00000 and the same serial number of 0000000002. The medication is manufactured by NDC with the NDC code 68382-035-16 for both forms. There is a warning to keep out of reach of children and to store at a temperature range of 68-77°F. The manufacturer's label should be consulted for a full list of ingredients.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 01)

This text appears to be a table showing the interaction of various drugs with CYP2D6 EM's and PM's, and their effects on the analyte venlafaxine. The table includes PK fold change and 90% C recommendations for Cmax and AUC. Some drugs are advised to be avoided for concomitant use while others require caution and monitoring, especially in patients with hypertension, the elderly or those with hepatic dysfunction. There are also some drugs where the clinical significance is unknown.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 02)

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 03)

This document appears to be a report on the effects of various factors on the pharmacokinetics (PK) of the analyte venlafaxine. These factors include hepatic and renal impairments, CYP2D8 polymorphism, age, and gender. The table includes recommendations for dose adjustments based on the fold change and 90% confidence intervals.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 04)

The text consists of three distinct elements: "eHCI", "H4C0 C", and "venlafaxine hydrochloride". The first two elements are not recognizable, hence there is no useful description that can be generated. The last element refers to a medication known as venlafaxine hydrochloride. This medication is classified as an antidepressant and is used to treat major depressive disorder, anxiety disorders, and panic disorder.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.